menu ☰
menu ˟

Biogen, AGTC enter agreement to develop gene therapies in ophthalmology

02 Jul 2015
Biogen and AGTC have entered into a collaboration and licensing agreement to develop gene-based therapies for multiple ophthalmic diseases, according to a press release from Biogen. Lead development programs include a clinical candidate for X-linked ...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.